Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in‑vitro study
Head Face Med
.
2023 Aug 18;19(1):35.
doi: 10.1186/s13005-023-00386-x.
Authors
Teresa F Brunner
1
,
Florian A Probst
2
,
Matthias Troeltzsch
2
,
Sabina Schwenk-Zieger
3
,
Julia L Zimmermann
4
,
Gregor Morfill
4
,
Sven Becker
5
,
Ulrich Harréus
6
,
Christian Welz
7
Affiliations
1
Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU, Munich, Germany.
[email protected]
.
2
Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU, Munich, Germany.
3
Department of Otolaryngology, Head and Neck Surgery, University Hospital, LMU, Munich, Germany.
4
Terraplasma GmbH, Garching, Germany.
5
Department of Otolaryngology, Head and Neck Surgery, University Hospital, EKU, Tubingen, Germany.
6
Department of ENT/Head and Neck Surgery, Asklepios Hospital, Bad Tolz, Germany.
7
HNO Munchen Nord, Munich, Germany.
PMID:
37596585
PMCID:
PMC10436649
DOI:
10.1186/s13005-023-00386-x
No abstract available
Publication types
Published Erratum